Healthcare / Health Information ServicesTokyo
$302.00
-7.00 (-2.27%)
FCF base 3Y
n/d
n/d CAGR · yield n/d
FCF base 5Y
n/d
n/d base · n/d expected
Precio de entrada
n/d
MOS 24% · confianza 25%
FCF escenarios
weak_data · normalized FCF $359.3M · quality 62.7/100
Ranking barato/determinista: CAGR esperado 5Y + downside bear + calidad del modelo + balance + capital allocation + data gate. No entra en buy-candidate si la data es débil o el CAGR 5Y no compensa.
SA Score
55/100
C
Piotroski
4/9
balance/quality
Valuation
50/100
+0.0% upside
5Y CAGR
+0.0%
50/100
Data QA
16/100
SEC 0%
Sin guardar todavía.
Market Cap
$7.3B
P/E
12.7x
↓EV/EBITDA
7.8x
↓ROE
14.6%
↑Gross Margin
26.9%
↓Debt/Equity
0.63
↑TradingView lightweight chart
Absolute Values (Left Axis)
Ratios / Percentages (Right Axis)
Financial statement dashboard
2022–2025 · 3 años de histórico normalizado
Revenue CAGR
+11.1%
FCF CAGR
+29.9%
FCF margin
5.2%
FCF / Net income
0.63x
Latest source
Provider fallback
Margin decomposition
Último año: revenue $6.93B · net income $573.5M · FCF $359.3M
Gross margin
Operating margin
Net margin
FCF margin
| Metric | TTM | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Income Statement | |||||
| Revenue | $6.93B | $6.93B | $5.43B | $5.26B | $5.05B |
| Net Income | $573.5M | $573.5M | $480.2M | $452.8M | $419.4M |
| EBITDA | $849.9M | $849.9M | $745.4M | $659.7M | $624.1M |
| EPS | 23.87 | 23.87 | 20.01 | 18.88 | 17.54 |
| Gross Margin | 26.9% | 26.9% | 30.8% | 29.8% | 28.6% |
| Operating Margin | 10.7% | 10.7% | 12.2% | 11.0% | 10.8% |
| Net Margin | 8.3% | 8.3% | 8.8% | 8.6% | 8.3% |
| Balance Sheet | |||||
| Debt/Equity | 0.63 | 0.63 | 0.40 | 0.41 | 0.46 |
| Current Ratio | 1.55 | 1.55 | — | — | — |
| Cash Flow | |||||
| Free Cash Flow | $359.3M | $359.3M | $622.9M | $206.8M | $163.8M |
| Returns | |||||
| ROE | 14.6% | 14.6% | 13.6% | 14.1% | 14.3% |
| Valuation | |||||
| P/E | 12.66 | 12.66 | 10.43 | 9.94 | 12.33 |
| EV/EBITDA | 7.79 | 7.79 | 3.98 | 4.42 | 5.89 |
| P/B | 1.85 | 1.85 | 1.42 | 1.40 | 1.76 |
| Growth & Yield | |||||
| Revenue Growth | 27.6% | 27.6% | 3.2% | 4.2% | — |
| EPS Growth | 19.3% | 19.3% | 6.0% | 7.7% | — |
| Dividend Yield | 3.3% | 3.3% | — | — | — |
Revenue, Net Income & Free Cash Flow ($B)
Margins (%)
Returns (%)
Leverage & Liquidity
3Y implied EPS CAGR
3.9%
EPS terminal req.
$26.80
Spread vs growth
15.4%
5Y implied EPS CAGR
6.3%
EPS terminal req.
$32.42
Spread vs growth
13.0%
10Y implied EPS CAGR
8.1%
EPS terminal req.
$52.22
Spread vs growth
11.1%
Qué te dice: cuánto EPS CAGR está descontando el precio si sales al múltiplo terminal indicado. Si el growth observado queda por debajo, el mercado está pidiendo una ejecución muy fina.
Total return
+38.1%
Start / end P/E
11.2x → 12.7x
EPS bridge
20.01 → 23.87
Residual
+2.5%
Simple additive decomposition: total return = EPS growth contribution + P/E multiple contribution + dividend contribution + explicit residual. The residual captures cross-terms, buybacks/share-count effects, FX, special dividends, data noise and methodology mismatch so the bridge always reconciles.